# Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

> **NCT04558580** · PHASE3 · WITHDRAWN · sponsor: **University of South Alabama**

## Conditions studied

- Refractory Partial Seizures

## Interventions

- **DRUG:** Rufinamide

## Key facts

- **NCT ID:** NCT04558580
- **Lead sponsor:** University of South Alabama
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558580, "Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04558580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*